Free Trial

Kintara Therapeutics (KTRA) Competitors

$0.26
+0.02 (+8.25%)
(As of 06/24/2024 ET)

KTRA vs. MLND, OCUP, RPHM, IMMX, EGRX, BRNS, CLNN, LPTX, CASI, and LPCN

Should you be buying Kintara Therapeutics stock or one of its competitors? The main competitors of Kintara Therapeutics include Millendo Therapeutics (MLND), Ocuphire Pharma (OCUP), Reneo Pharmaceuticals (RPHM), Immix Biopharma (IMMX), Eagle Pharmaceuticals (EGRX), Barinthus Biotherapeutics (BRNS), Clene (CLNN), Leap Therapeutics (LPTX), CASI Pharmaceuticals (CASI), and Lipocine (LPCN). These companies are all part of the "medical" sector.

Kintara Therapeutics vs.

Kintara Therapeutics (NASDAQ:KTRA) and Millendo Therapeutics (NASDAQ:MLND) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, community ranking, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

Kintara Therapeutics' return on equity of 0.00% beat Millendo Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Kintara TherapeuticsN/A N/A -257.25%
Millendo Therapeutics N/A -91.03%-72.44%

0.6% of Kintara Therapeutics shares are held by institutional investors. 0.2% of Kintara Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kintara TherapeuticsN/AN/A-$14.65M-$4.07-0.06
Millendo TherapeuticsN/AN/A-$36.41MN/AN/A

In the previous week, Kintara Therapeutics' average media sentiment score of 0.00 equaled Millendo Therapeutics'average media sentiment score.

Company Overall Sentiment
Kintara Therapeutics Neutral
Millendo Therapeutics Neutral

Kintara Therapeutics received 16 more outperform votes than Millendo Therapeutics when rated by MarketBeat users.

CompanyUnderperformOutperform
Kintara TherapeuticsOutperform Votes
16
88.89%
Underperform Votes
2
11.11%
Millendo TherapeuticsN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kintara Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Millendo Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Kintara Therapeutics has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500. Comparatively, Millendo Therapeutics has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500.

Summary

Kintara Therapeutics beats Millendo Therapeutics on 7 of the 8 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KTRA vs. The Competition

MetricKintara TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$14.51M$7.00B$5.07B$8.31B
Dividend YieldN/A2.76%5.28%4.09%
P/E Ratio-0.0620.53159.0617.53
Price / SalesN/A254.592,257.1976.09
Price / CashN/A31.7932.9331.84
Price / Book-0.045.554.724.19
Net Income-$14.65M$145.84M$108.29M$216.21M
7 Day Performance46.54%0.31%-1.05%-0.37%
1 Month Performance56.13%-1.54%-3.01%-2.36%
1 Year Performance-91.70%-7.20%-2.55%0.31%

Kintara Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MLND
Millendo Therapeutics
0 of 5 stars
$2.03
+1.0%
N/A+74.2%$38.66MN/A0.0012Gap Down
OCUP
Ocuphire Pharma
2.4695 of 5 stars
$1.58
-1.3%
$18.75
+1,086.7%
-59.1%$40.95M$19.05M-3.2214Gap Up
RPHM
Reneo Pharmaceuticals
1.4319 of 5 stars
$1.62
+2.5%
$11.01
+579.8%
-77.0%$54.14MN/A-0.758News Coverage
IMMX
Immix Biopharma
3.0784 of 5 stars
$2.04
+6.3%
$14.00
+586.3%
-12.6%$53.88MN/A-2.1914Gap Down
EGRX
Eagle Pharmaceuticals
4.3184 of 5 stars
$4.14
+1.7%
$17.00
+310.6%
-78.2%$53.78M$316.61M3.51134Analyst Forecast
BRNS
Barinthus Biotherapeutics
1.7283 of 5 stars
$1.32
+5.6%
$5.50
+316.7%
N/A$51.52M$800,000.00-0.72130Gap Down
High Trading Volume
CLNN
Clene
2.4708 of 5 stars
$0.40
+1.3%
$6.50
+1,540.2%
-52.2%$50.90M$650,000.00-0.8682Gap Up
LPTX
Leap Therapeutics
2.208 of 5 stars
$1.92
-2.0%
$11.00
+472.9%
-50.4%$49.15M$1.50M-0.8054Gap Up
CASI
CASI Pharmaceuticals
3.5258 of 5 stars
$3.66
+4.6%
$6.00
+63.9%
+46.7%$49.04M$33.88M-1.61176Analyst Forecast
News Coverage
Gap Down
LPCN
Lipocine
0 of 5 stars
$8.98
+16.0%
N/A+91.4%$48.04M$500,000.00-5.2517Gap Up

Related Companies and Tools

This page (NASDAQ:KTRA) was last updated on 6/25/2024 by MarketBeat.com Staff

From Our Partners